Research & Innovation
Boston Children's Hospital is a world leader in opening new avenues of "translational research," bringing laboratory advances to the bedside and doctor's office as quickly as possible. When doctors in other states or other countries need help diagnosing or treating vascular anomalies like the ones that cause Kasabach-Merritt phenomenon, they often come to us. We have more experience helping more children with KMP than any other hospital in the world.
And we’re constantly increasing our base of knowledge. Physicians and researchers at the VAC are actively reviewing our extensive database with more than 125 cases complicated by KMP. As our database grows, it will help shine more light on a widely misunderstood condition. More importantly, consolidating knowledge about treatment, side effects and outcomes in this database will help us treat your child more effectively.
The VAC conducts research that may lead to the development of new, more effective therapies and perhaps ultimately result in ways to prevent these anomalies. Read more about our research.
|Clinical and Translational Study Unit|
|Read about a day in the life of the Clinical and Translational Study Unit at Children’s.|